KELLER, T. H.; PICHOTA, A.; YIN, Z. A Practical View of Druggability. Curr. Opin.
in Struct. Biol.: v. 10, 357-361, 2006.
KHAN, M. T.; SYLTE, I. Predictive QSAR Modeling For the Successful
Predictions of the ADMET Properties of Candidate Drug Molecules. Curr. Opin.
in Struct. Biol.: v. 4, 141-149, 2007.
KUBINYI, H. Strategies and Recent Technologies in Drug Discovery. Pharmazie.
v. 50, 647-662, 1995.
JORDAN, A. M.; ROUGHLEY, S. D. Drug Discovery Chemistry: A Primer for the
Non-specialist. Drug Disc. Today.: v. 14, 731-744, 2009.
LEACH, A. Molecular Modelling: Principles and Applications. Pearson Education
Limited: 2ª ed., 2001.
LENGAUER, T.; RAREY, M. Computacional Methods For Biomolecular Docking.
Curr. Opin. in Struct. Biol.: v. 6 (3), 402-405, 1996.
LEOPOLDO, P. T.; MACHADO, P. R.; ALMEIDA, R. P.; SCHRIEFER, A.; GIUDICE,
A.; DE JESUS, A. R.; HO, J. L.; GUIMARÃES, L. H.; BACELLAR, O.; CARVAlHO, E.
M. Differential Effects of Antigens from L. braziliensis Isolates from
Disseminated and Cutaneous Leishmaniasis on In Vitro Cytokine Production.
BMC Infect. Dis.: v. 75, 1-6, 2006.
LIPINSKI, C. A. Lead and Drug-Like Compounds: The Rule-of-Five Revolution.
Drug Disc. Tod.: Techno.: v. 1, 337-341, 2004.
LIPINSKI, C. A.; LOMBARDO, F.; DOMINY, B. W.; FEENY, P. J. Experimental and
Computational Aproaches to Estimate Solubility and Permeability in Drug
Discovery and Development Settings. Adv. Drug. Rev.: v. 48, 3-26, 2001.
LUNARDI, F.; GUZELA, M.; RODRIGUES, A. T.; CORRÊA, R.; EGER-MANGRICH,
I.; STEINDEL, M.; GRISARD, E. C.; ASSREUY, J.; CALIXTO, J. B.; SANTOS, A. R.
S. Trypanocidal and Leishmanicidal Properties of Substitution-Containing
Chalcones. Antimicrob. Agents Chemother.: v. 47, 1449-1451, 2003.
MAAROUF, M.; KOUCHKOVSKY, Y.; BROWN, S; PETIT, P. X.; ROBERT-GERO,
M. In Vivo Interference of Paromomycin with Mitochondrial Activity of
Leishmania. Exp. Cell. Res.: v. 232, 339-348, 1997.
MALLARI, J. P.; SHELAT, A.; KOSINSKI, A.; CAFFREY, C. R.; CONNELLY, M.;
ZHU, F.; MCKERROW, J. H.; GUY, K. Discovery of Trypanocidal
Thiosemicarbazone Inhibitors of Rhodesain and TbcatB. Bioorg. Med. Chem
Lett.: v. 18, 2883-2885, 2008.
MENG, C. Q; ZHENG, X. S.; NI, L.; ZHIHONG, Y.; SIMPSON, J. E.;
WORSENCROFT, K. J; HOTEMA, M. R.; WEINGARTEN, D.; SKUDLAREK, J. W.;
GILMORE, J. M.; HOONG, L. K.; HILL, R. R.; MARINO, E. M.; SUEN, K. L.;